HEALTHglobal
AstraZeneca to boost cell therapy capabilities with new China investment
Single source
Updated 2 hours ago
First seen March 20, 2026 07:14:10Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
The planned Shanghai facility extends a yearslong push into the field and will support CAR-T therapies AstraZeneca is making for autoimmune disease and cancer.